Agilent's Q2 Revenues Drop 25 Percent; LS Revenues Down 7 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday that its second-quarter 2009 revenues declined 25 percent to $1.1 billion from $1.5 billion as its Electronic Measurement segment was hit particularly hard by the current economic downturn.

The Santa Clara, Calif.-based firm said that revenues for its Bio-Analytical Measurement segment were down 6 percent to $498 million from $530 million. Within that segment, its life science sales decreased 7 percent to $241 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.